A single-center clinical study on Linggui Zhugan Decoction to improve palpitation discomfort in patients with Long COVID based on the theory of one-qi circulatio
- Conditions
- ong COVID
- Registration Number
- ITMCTR2024000051
- Lead Sponsor
- Jiangyan Hospital Affiliated to Nanjing University of Chinese Medicine
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- All
- Target Recruitment
- Not specified
1. Meets the diagnostic criteria for LongCOVID; 2. Meets the diagnostic criteria for cardiac neurosis; 3. Age range from 18 to 70 years old, regardless of gender; 4. The patient agrees to participate in this clinical study, voluntarily signs an informed consent form, and agrees to participate in visits, examinations, and treatment in accordance with the requirements of the research protocol.
1. Concomitant mental and psychological disorders such as severe anxiety and depression; 2. And patients with severe primary diseases such as cardiovascular, cerebrovascular, liver, kidney, and hematopoietic systems, malignant tumors, and other serious comorbidities; 3. Pregnant or lactating women; 4. Has received relevant treatment and may affect the observation indicators of the effect; 5. Suspected to have a history of drug abuse or other patients who do not meet the inclusion criteria.
Study & Design
- Study Type
- Interventional study
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Tongue diagnosis evaluation;Olink;
- Secondary Outcome Measures
Name Time Method HAMA Score\HAMD Score;EQ-5D-5L Score;Traditional Chinese Medicine Symptom Score;PSQI Score;